Cronos Group (CRON) Competitors $2.50 -0.02 (-0.79%) Closing price 10/21/2025 04:00 PM EasternExtended Trading$2.48 -0.02 (-1.00%) As of 10/21/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRON vs. ACB, CGC, OGI, SNDL, TLRY, VKTX, LNTH, MIRM, ZLAB, and ADMAShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Viking Therapeutics (VKTX), Lantheus (LNTH), Mirum Pharmaceuticals (MIRM), Zai Lab (ZLAB), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Aurora Cannabis Canopy Growth Organigram Global SNDL Tilray Brands Viking Therapeutics Lantheus Mirum Pharmaceuticals Zai Lab ADMA Biologics Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment. Which has higher valuation & earnings, ACB or CRON? Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.17$1.63M-$0.19-27.05Cronos Group$117.61M8.14$41.08M$0.0550.00 Do institutionals & insiders believe in ACB or CRON? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 6.9% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is ACB or CRON more profitable? Cronos Group has a net margin of 14.19% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Cronos Group 14.19%-3.78%-3.62% Does the media favor ACB or CRON? In the previous week, Aurora Cannabis had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.00 beat Aurora Cannabis' score of 0.50 indicating that Cronos Group is being referred to more favorably in the news media. Company Overall Sentiment Aurora Cannabis Positive Cronos Group Positive Which has more risk & volatility, ACB or CRON? Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Do analysts prefer ACB or CRON? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.80Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryAurora Cannabis beats Cronos Group on 9 of the 16 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$964.89M$3.01B$6.22B$10.68BDividend YieldN/A57.76%5.72%4.88%P/E Ratio50.0023.5929.1427.22Price / Sales8.14759.15577.06128.38Price / Cash5,415.63171.3937.5161.65Price / Book0.865.4112.476.59Net Income$41.08M$33.06M$3.32B$276.14M7 Day Performance-3.10%-0.68%0.80%-0.72%1 Month Performance-3.47%8.13%7.32%2.47%1 Year Performance9.17%-2.15%63.84%33.90% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group1.0654 of 5 stars$2.50-0.8%N/A+17.4%$964.89M$117.61M50.00450Positive NewsACBAurora Cannabis0.5417 of 5 stars$5.40+1.9%N/A-6.7%$303.60M$357.88M-28.421,130CGCCanopy Growth0.8949 of 5 stars$1.37flatN/A-68.4%$328.59M$274.92M-0.453,150OGIOrganigram Global0.7391 of 5 stars$1.92+0.5%N/A-2.3%$257.94M$223.82M38.41860News CoverageSNDLSNDL3.0686 of 5 stars$2.48-1.6%$4.50+81.5%+11.9%$651.68M$944.25M-9.182,516TLRYTilray Brands3.3295 of 5 stars$1.69-1.7%$2.00+18.3%-6.3%$1.86B$210.48M-0.742,842VKTXViking Therapeutics3.999 of 5 stars$33.91+1.0%$86.42+154.8%-48.7%$3.81BN/A-22.1620LNTHLantheus4.5923 of 5 stars$54.59+2.0%$74.50+36.5%-48.5%$3.71B$1.53B14.52700Trending NewsMIRMMirum Pharmaceuticals4.1416 of 5 stars$72.17-0.7%$76.50+6.0%+75.3%$3.63B$429.16M-59.64140ZLABZai Lab2.6629 of 5 stars$31.23+3.3%$56.35+80.4%+4.1%$3.49B$398.99M-15.311,869Gap UpADMAADMA Biologics3.6857 of 5 stars$14.55+0.1%$27.67+90.1%-5.8%$3.47B$426.45M16.92530 Related Companies and Tools Related Companies ACB Alternatives CGC Alternatives OGI Alternatives SNDL Alternatives TLRY Alternatives VKTX Alternatives LNTH Alternatives MIRM Alternatives ZLAB Alternatives ADMA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRON) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
